Clinical Trial Supply East Asia 2023

The leading clinical trial supply conference in East Asia helping you enhance your end-to-end clinical strategy

5 - 6

December

2023
  • JW Marriott Hotel Seoul, South Korea
  • Ticketed
  • Why attend?
  • Agenda
  • Speakers
  • Plan Your Visit
  • Sponsors
  • Media Centre
  • Contact Us
close

Why attend?

Agenda

  • 5 Dec 2023
  • 6 Dec 2023
Expand All

8 AM

Registration and refreshments

8:50 AM

Chairperson’s opening remarks

9 AM

KEY NOTE Choosing the right CRO: Essential considerations for a successful partnership

  • Recognizing common misconceptions when selecting a CRO that may not align with your values and trial requirements
  • Determining the essential resources and capabilities that the CRO must possess to ensure the success of your trial
  • Managing that all important budget to avoiding overspending

Speakers

Sueun Song
Division Head of Clinical Development, Celltrion

9:30 AM

Reserved for N-SIDE

10 AM

Master protocols in biotech: Design and implementation

  • Concept of master protocols
  • FDA perspectives on mater protocols
  • Operation of complex study design
  • Examples of mater protocols

Speakers

Nari Yun
Executive Director, Clinical Development, GI Innovation Inc.

10:30 AM

The Future of Clinical Trials: Clinical Innovation Solutions Utilizing of Artificial Intelligence (AI)

• The key trends in the clinical trials landscape
• How to do CROs use AI in clinical trials
• Real-world cases of AI and CRO

Speakers

YOONI KIM
Vice President Clinical Services, Novotech

11 AM

Morning refreshments and networking

STREAM B: Clinical Trial Supply

11:30 AM

Cold chain management and optimal shipping practices

  • Exploring how organisations can improve cold chain management, focusing on temperature-sensitive product handling, storage
  • Providing insights and strategies for effectively managing cold chain operations, such as risk assessment
  • Discussing the challenges of shipping temperature-sensitive products and outlining best practices

Speakers

KangPyo Lee
Vice President Hanul TL

12 PM

Clinical Trial Sourcing in Asia: Strategies for Success

  • Sourcing for clinical trials in Asia: We highlight the key things to consider when looking to source pharmaceutical products for your clinical trials in Asia for domestic supply, regional, and global supply
  • What to look for when you start sourcing for your project: We discuss the three top items to consider when beginning the process of sourcing for your clinical trial
  • How to find the right vendor to ensure success: Selecting the right vendor is a critical part of any company’s strategy for success. What are some of the most important things to look for when searching for a vendor

Speakers

George Vlachos
Director, Clinical Trial Supply , Akesa

12:30 PM

Clinical supply strategies: tailoring approaches for successful trials

  • Addressing the significance of tailoring clinical supply strategies to match the unique requirements of each trial
  • Examining proactive steps to manage risks, such as regulatory changes, supply chain disruptions, and unexpected patient enrollment
  • Discussing the ability to adapt supply strategies in response to unforeseen challenges, minimizing disruptions

Speakers

DaeMan Moon
Director, Team Leader, Global Clinical Supply Management Team, Celltrion

1 PM

Lunch and networking

2 PM

IATA Temperature Control Regulations (TCR) on Clinical trials supply chain

  • Influence of TCR (Time, Temperature, and Condition) on Pharmaceutical Transportation
  • Effective Application of Time and Temperature Sensitive Labels
  • Ensuring Compliance with TCR Regulations in Clinical Trials

Speakers

Baek-Jae KIM
Country Manager Korea, IATA

2:30 PM

Reserved for the Event Partner

3 PM

The impact of Digital Transformation in Precision Medicine on Clinical Supply

·       Integrating precision medicine data into supply chain logistics for tailored patient treatments

·       Ensuring data security and compliance with evolving digital healthcare regulations

·       Optimizing clinical supply chain efficiency through AI-driven decision-making based on precision medicine data

Speakers

SoYoung Chun
Medical Director, Trial Informatics

3:30 PM

Afternoon refreshments and networking

4 PM

How to manage the Investigational Product in clinical trials

·       Points to consider in relation to Investigational Product(including comparator) when conducting clinical trials

·       Key Strategic Exploration for Efficient Supply and the use of IRT

·       Discussing effective risk management strategies to anticipate and mitigate potential challenges, ensure uninterrupted supply, and minimize delays

Speakers

HyeJung Yang
Clinical Project Manager, MedPacto

4:30 PM

PANEL DISCUSSION: Mitigating unnecessary delays in clinical supply logistics: Huddle and Solutions

  • Strategies to Minimize Delays in Clinical Supply Logistics
  • Implementing Effective Communication through Huddles
  • Practical Solutions for Streamlining Supply Chain Processes

Speakers

Jaehyun Park
Managing Director, Animuscure
Sean Smith
Biological Threat Exclusion Coordinator (BTEC), U.S. Customs and Border Protection

5:15 PM

Chairperson’s closing remarks

END OF DAY 1 AND NETWORKING DRINKS

8:15 AM

Registration and refreshments

8:50 AM

Chairperson’s opening remarks

STREAM B: Clinical Trial Supply

9 AM

How to navigate sourcing for clinical trials in China

·       Are you confused about where to start sourcing in China?

·       Do you have concerns about quality and transparency when investing into a trial in China?

·       Have time, language, and cultural differences affected the efficiency of your project?

Speakers

Guoqing Yang
Clinical compliance and quality assurance director, Shanghai Henlius Biotech

9:30 AM

Reserved for the Event Partner

10 AM

Selecting the optimal CMO Partner for product manufacturing: Key considerations and best practices

·       Understanding the importance of aligning with a CMO that shares your values and vision to foster a strong partnership

·       Evaluating the criteria to assess CMO capabilities

·       Emphasizing the importance of clear communication channels and effective collaboration between your team and the CMO

Speakers

Jungwon Jung
Manufacturing Manager, HK inno-N

10:30 AM

Streamlining the End-to-End pharmaceutical supply Chain: Enhancing efficiency and quality

·       Understanding the complexities and challenges of the end-to-end pharmaceutical supply chain, from manufacturing to patient delivery

·       Addressing regulatory requirements and compliance

·       How did we implement effective strategies to enhance the end-to-end pharmaceutical supply chain

Speakers

Hyesung Shin
Managing Director, Division Head Clinical Research Development Division, TiumBio

11 AM

Morning refreshments and networking

11:30 AM

Explore importing and exporting requirements for biological materials and how preparation is everything in the modern world

·       Understanding the requirement and options for declaring biological materials to U.S. Customs and Border Protection (CBP)

·       Review of key U.S. regulatory agency authorities, such as CDC, FDA, USDA, and CBP

·       Discovering the latest non-compliant shipment issues for biological materials and pharma products and tips to avoid them

·       Learn about valuable resources and contacts for assistance

Speakers

Sean Smith
Biological Threat Exclusion Coordinator (BTEC), U.S. Customs and Border Protection
Gina Reneau
Biological Threat Exclusion Coordinator, U.S. Customs & Border Protection

12 PM

Supply Chain Panel: Ensuring the highest level of collaboration between clinical trial supply and clinical operations

  • Ascertaining how clinical supply can get a seat at the table with clinical operations to streamline capabilities
  • Discovering how teams can collaborate and how technology can enable this
  • Sourcing raw materials in order to produce products
  • Overcoming logistical challenges within supply chain
  • Discussing how to provide products to patient

12:45 PM

Lunch and networking

1:45 PM

Prize Draw

Join us for a chance to win one of our prizes, including Apple products

2 PM

Speaker Hosted Roundtables

Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

Roundtable session lasts for 45 minutes, and we’ll have a 45min wrap up session

ROUNDTABLE 1: Establishing strategies for vendor management and oversight to strengthen collaboration
Seoyeon Hyun, Clinical Development Director, ILIAS Biologics

ROUNDTABLE 2:
Navigating global supply chain hurdles when shipping cold chain supplies overseas
Guoqing Yang, Executive Director, Clinical Quality Assurance, Shanghai Henlius Biotech

ROUNDTABLE 3: Decentralized clinical trials and technology

Moon Hwan Kim, Chief Technology Officer, Veraverse

Speakers

Seoyeon Hyun
Clinical Development Director, ILIAS Biologics
Guoqing Yang
Clinical compliance and quality assurance director, Shanghai Henlius Biotech
Moon Hwan Kim
Chief Technology Officer, Veraverse

2:45 PM

Chairperson’s closing remarks

END OF CONFERENCE

Speakers

Select a speaker to learn more

Back
Moon Hwan Kim
Chief Technology Officer, Veraverse

Session Details:

Speaker Hosted Roundtables

2023-12-06, 2:00 PM

View In Agenda
Next speaker
Back
Tina Sun
Study & Site Operations Country Head (Taiwan)- Novartis

Education:

  • National Taiwan University, Pharmacy (1993-1997)
  • National Taiwan University of Science and Technology, EMBA (2022-2023)

Working experience:

Current: Novartis SSO country head試驗監測部長/臨床研究部/全球藥物研發中心

  • Head of Clinical Operations, Taiwan & Hong Kong, Eli Lilly Taiwan (2010-2019)
  • Trial Monitoring (TMO) Country Head, Novartis Taiwan (2019-2023)
  • Study & Site Operations (SSO) Country Head, Novartis Taiwan (2023~)

External Engagement:

  • TransCelerate Taiwan Country Lead (2013~)
  • Taiwan Clinical Research Association (TCRA) ex-president (2014); Executive Director (2015~)

Tina has over 20 years of experience in clinical operations. She was Head of Clinical Operations to manage Taiwan & Hong Kong for 10 years when at Eli Lilly before joined Novartis as the TMO Country Head in Taiwan, 2019. Tina is interested in external engagement activities through her journey in clinical operations, she is Transcelerate Taiwan Country lead since 2013 and was ex-president (2014) and current executive director in Taiwan Clinical Research Association

Next speaker
Back
Jaehyun Park
Managing Director, Animuscure

August, 2018 ~ Adjunct Professor, College of Pharmacy, Sunchon National University

January, 2023 ~ Managing Director, AniMusCure Inc., Suwon, Korea

< EDUCATION >

B.S. Pharmacy, College of Pharmacy, Sungkyunkwan University, Korea

M.S. Biochemistry, College of Pharmacy, Sungkyunkwan University, Korea

Ph.D. Biochemistry, College of Pharmacy, Sungkyunkwan University, Korea

< PROFESSIONAL EXPERIENCES >

- Assistant Manager, Kolon Pharmaceuticals Inc.

- Assistant Manager, Kolon Life Science, Ins., Seoul, Korea

- Research Fellow, Daewoong Pharmaceutical Co.

- Deputy Director, DanDi Bioscience, Inc.,

- Director, Selecxine, Inc.

- Managing Director, Genencell Co., Ltd.

Session Details:

PANEL DISCUSSION: Mitigating unnecessary delays in clinical supply logistics: Huddle and Solutions

2023-12-05, 4:30 PM

View In Agenda
Next speaker
Back
SANGHO MA
Chief Development Officer, Bilix

Sang Ho, MA is Vice President, at the Bilix which Biotech in south korea. He is expert member of MFDS (Ministry of Food & Drug Safety) & judge member of KDDF. (Korea Drug Development Fund) His current research area is acute & chronic inflammatory disease & drug delivery system. Pursuing this R&D agenda he has recently been working with global CRO & CMO. He wrote his Ph.D. on the specific chemistry for drug development at the Graduate Institute in south korea. Since 2006, he has been a senior researcher of JW Pharma & GC Pharma for more than 14 years. And he joined Bilix in 2019 and is currently the head of the research institute and Chief Development Officer.

Next speaker
Back
Guoqing Yang
Clinical compliance and quality assurance director, Shanghai Henlius Biotech

Session Details:

How to navigate sourcing for clinical trials in China

2023-12-06, 9:00 AM

Session Details:

Speaker Hosted Roundtables

2023-12-06, 2:00 PM

View In Agenda
Next speaker
Back
Sol Han
Chief Medical Officer, Cyrus Therapeutics
Next speaker
Back
Nari Yun
Executive Director, Clinical Development, GI Innovation Inc.

Dr. Yun began her career at Hanmi Pharmaceuticals, took the major role in managing all activities associated with the clinical development programs for key assets including long-acting insulin, GLP-1 agonist and GLP-1/GCG dual agonist. She engaged in full courses of drug development, ranging from CDP/TPP development, clinical strategy formulation and operations, licensing out and co-development with partners. She also served as a strategic consultant in IQVIA, worked on consulting projects for key business decisions, including business planning and strategy formulation, asset valuation and pricing & reimbursement strategy for various drugs etc.

In September 2019, Dr. Yun joined to GI Innovation and has led clinical collaboration agreement of company’s immunooncology asset with global pharmaceutical companies, including MSD and AstraZeneca. She is now serving as a head of clinical development.

Dr. Yun is a registered pharmacist in Korea and was educated at School of Pharmacy, Sunkyunkwan University, where she received her PhD in pharmacology in 2012.

Session Details:

Master protocols in biotech: Design and implementation

2023-12-05, 10:00 AM

View In Agenda
Next speaker
Back
Taegyun Park
Head of R&D, Qratis

2022 Sungkyunkwan University School of Medicine, Ph.D. Clinical Epidemiology

2019 Master of Pharmacy, Sungkyunkwan University Graduate School

1996 Bachelor of Pharmacy, Sungkyunkwan University Graduate School

2023 ~                Head of Research and development in Quratis

2016 ~ 2022(former) Medical Manager in ChungKundang

2001 ~ 2016(former) GSK Medical

Next speaker
Back
Jessica Thongcharen
DIRECTOR, GLOBAL PATIENT SAFETY & EVALUATION – CLINICAL OPERATIONS

A highly skilled pharmacovigilance professional with vast experience in pharmacovigilance operations and regulatory intelligence in the APAC region and internationally. Strong leadership skills in both; project and people management with 18 years of working experience in the healthcare and pharmaceutical industry. Proven ability to set up new Pharmacovigilance (PV) operations, oversee PV compliance, audit, and quality management in the Asia Pacific region with positive track record of successful global PV audit and inspections. A qualified healthcare professional with post-graduate degrees in; Pharmacovigilance and Pharmacoepidemiology (specialized in Risk Identification and Quantification) and Business Administration.

Strong knowledge of relevant Codes of Conduct, aggregate reporting, compliance monitoring, safety databases and hands-on experiences in managing organization M&A as change agents.

Next speaker
Back
Young Su (Bobby) Noh
Director, Head of Clinical Science, Hanmi Pharm

Dr. Noh received his Ph.D. in pharmacy Kyung Hee University and joined Hanmi Pharma in 2009, bringing more than 15 years of experience in clinical research and development. He is responsible for leading clinical program with NMEs or NBEs in multi-therapeutic area: including metabolic diseases and rare disease as well as oncology and hematology. He has lot of experience for collaborating with global big pharma as well as biotech companies.

Previously, he served as an adjunct professor, department of regulatory science for Kyung Hee university and an expert member of external evaluation committee of KDDF.

Next speaker
Back
Sueun Song
Division Head of Clinical Development, Celltrion

EDUCATION :

l  Duksung Women's University, College of Pharmacy

l  Sookmyung Women’s University. Graduate School of Clinical Pharmacy

PROFESSIONAL EXPERIENCE

l  Current: Celltrion, Head of Clinical Development Division

l  Dec 2013 ~ : Celltrion

l  C&R Research

l  PPD Korea

Session Details:

KEY NOTE Choosing the right CRO: Essential considerations for a successful partnership

2023-12-05, 9:00 AM

View In Agenda
Next speaker
Back
KangPyo Lee
Vice President Hanul TL

Session Details:

Cold chain management and optimal shipping practices

2023-12-05, 11:30 AM

View In Agenda
Next speaker
Back
Seoyeon Hyun
Clinical Development Director, ILIAS Biologics

Seoyeon Hyun is the Head of Clinical Development at ILIAS Biologics. In her role, she is responsible for overseeing the overall clinical development of the company's pipeline and leading global clinical trials for engineered exosome therapeutics.

With over 20 years of experience, she has handled various clinical development tasks, including Phase 1-3 clinical trials for new drug approvals as well as global clinical trials sponsored by multinational pharmaceutical companies. Before joining ILIAS Biologics in September 2021, she held a position overseeing new drug clinical development at a European biotech company, where she led multinational clinical trials in Europe. She has also served as a Clinical Research Manager at MSD and as a clinical project manager for new drug development at Boehringer Ingelheim and SK Chemicals.

Seoyeon Hyun holds a bachelor’s degree from Ewha Womans University College of Pharmacy and a master’s degree in physical pharmacy from Seoul National University.

Session Details:

Speaker Hosted Roundtables

2023-12-06, 2:00 PM

View In Agenda
Next speaker
Back
Jungwon Jung
Manufacturing Manager, HK inno-N
  1. 2001.09~ present: HK inno-N. Manufacturing Team part manager.

; Quality assurance Team / Cell & Gene project Team / Technical development Team / Manufacturing Team

  1. 2000.09~2001.09 : Green Cross Quality control team (Bio Pharm)
  2. 1999.10~2000.09 : LG Chemical Quality assurance team (Quinolones antibiosis)

Session Details:

Selecting the optimal CMO Partner for product manufacturing: Key considerations and best practices

2023-12-06, 10:00 AM

View In Agenda
Next speaker
Back
DaeMan Moon
Director, Team Leader, Global Clinical Supply Management Team, Celltrion

2014.10- Present  Team Leader/Director, Global Supply Chain Management in Celltrion

2012.01-2014.10   Manager, Material Management in Celltrion

Session Details:

Clinical supply strategies: tailoring approaches for successful trials

2023-12-05, 12:30 PM

View In Agenda
Next speaker
Back
Juhee Jeon
PV Manager, PV Team Leader, HANA Pharm.

Ms. Juhee Jeon graduated from Korea University with a Master’s of Science in Medical Microbiology (Virology & Immunology). She has been working in the field of medical information, drug safety in clinical trial, pharmacovigilance and GCP/GVP quality management at pharmaceutical companies and CROs for more than 18 years. Currently, she is responsible for managing drug safety monitoring and pharmacovigilance at Hana Pharm in Korea.

 

Next speaker
Back
HyeJung Yang
Clinical Project Manager, MedPacto

Hyejung Yang is the Clinical Research Manager and Clinical Research Team Lead at MedPacto Inc,. She has almost 12 years of experience in Clinical Research Project management by local pharmaceutical companies.

Session Details:

How to manage the Investigational Product in clinical trials

2023-12-05, 4:00 PM

View In Agenda
Next speaker
Back
YOHAN BAE
Executive Director, Clinical Development Division, Kangstem Biotech

Yohan Bae is Executive Director, Clinical Development Division at Kangstem Biotech Co. Ltd since he joined in Mar 2020. He has almost 30 years of drug development experience ranging local and global regulatory affairs, clinical development, and patient access for pharmaceutical and medical device. Before he joined in Kangstem Biotech, Mr. Bae has worked for large international pharma and medical device companies such as Alcon, Bristol-Myer Squibb, and Boehringer-Ingelheim. He holds a master’s degree in Pharmacology from Pharmacy College, Kyunghee University.

Next speaker
Back
SoYoung Chun
Medical Director, Trial Informatics

Session Details:

The impact of Digital Transformation in Precision Medicine on Clinical Supply

2023-12-05, 3:00 PM

View In Agenda
Next speaker
Back
Baek-Jae KIM
Country Manager Korea, IATA

BJ (Baek-Jae) Kim, Ph.D., is the IATA Country Manager Korea, based in Seoul, Republic of Korea. BJ leads a team of 3 (Mr. HT Lee, Ms. Anna Park, and Ms. Hyein Jeon) in the Korea field office work.

Prior to joining IATA in Aug 2019, BJ has about 25 years of aviation experience, including 6 years in United Airlines, 4 years in Air France, and 16 years in Qatar Airways as Airport Services Manager in ICN airport, the Republic of Korea.

BJ holds a Ph.D. and Master of Aviation Business Administration from the Korea Aerospace University (KAU) and a Bachelor's degree in Economics from Hankuk University of Foreign Studies (HUFS) in the Republic of Korea.

BJ is a citizen of the Republic of Korea. He is a Christian and married with 2 children. BJ enjoys hiking, mountain climbing, and other sports in his spare time.

Session Details:

IATA Temperature Control Regulations (TCR) on Clinical trials supply chain

2023-12-05, 2:00 PM

View In Agenda
Next speaker
Back
Hyesung Shin
Managing Director, Division Head Clinical Research Development Division, TiumBio

Hyesung Shin, managing director of TiumBio Co., Ltd has worked more than 23 years of experience in clinical trial development and operations.

She had worked during 13 years for global pharmaceutical companies at Eli Lilly, Novo Nordisk and Novartis and 6 years at Abbott for medical devices clinical development and had experienced in Korean Biotech companies of BioPharm Solutions, Aptabio Therapeutics, TiumBio for new drug development and managing phase I/II Clinical Trial.

The works focused on managing clinical trial plan for new drug development, regulatory Filing for FDA/EMEA/MFDS IND, orphan drug Designation, vender management including CRO/Clinical Supplies/CDMO and development of  market strategy.

Session Details:

Streamlining the End-to-End pharmaceutical supply Chain: Enhancing efficiency and quality

2023-12-06, 10:30 AM

View In Agenda
Next speaker
Back
A Young Kim
R&D division Team leader, Jeil pharm
Next speaker
Back
Shin-Il Kim
Chief Scientific Officer, THERABEST

Shin-Il Kim is currently a CSO of Therabest Co., Ltd., a biopharmaceutical company that develops a platform for iPSC-derived immune cells. Prior to joining, he was a R & D director at aceRNA Technologies Co., Ltd., spun off from Center for iPS Cell Research and Application (CiRA) at Kyoto University.

Dr. Kim obtained his Ph.D. in molecular biology from University of Wisconsin-Madison in 2008. He then began his studies of TGF-b signaling in cancer models as a postdoctoral fellow at the University of California-San Francisco. In 2011, he moved to CiRA where Nobel Prize winner Shinya Yamanaka who first succeeded in establishment of iPS cells and became an assistant professor in 2017. He has extensive experience in the fields of genome engineering, iPSC differentiation, and cancer research.

Next speaker
Back
YOONI KIM
Vice President Clinical Services, Novotech

Head of Clinical Services in Novotech with >22 years’ experience in clinical research industry of CROs, Pharmaceutical company as well as academic research institute. Scientifically qualified as PhD majored in Preventive Medicine in Seoul National University. Experienced in all aspects of clinical research operations management. Broad range to cover Clinical Operations, Study Start-up, Regulatory Affairs, Project Management, Medical Affairs, Pharmacovigilance, Data Management, Business Operations as well as SMO. Joined Novotech in 2016 as head of Asia-Pac region and moved role to global coverage of clinical services in 2021.

Session Details:

The Future of Clinical Trials: Clinical Innovation Solutions Utilizing of Artificial Intelligence (AI)

2023-12-05, 10:30 AM

View In Agenda
Next speaker
Back
Marine du Jardin
APAC Regional Manager & Partnership Lead, N-SIDE
Next speaker
Back
Amaury Jeandrain
Vice President of Strategy, N-SIDE

Amaury Jeandrain has a Master’s Degree in Business Engineering with a specialization in supply chain management. After working for a CRO, he joined N-SIDE where he supported the optimization of hundreds of trials from different indications and pharmaceutical companies, providing services ranging from risk-based optimization to clinical trial design and solving drug supply shortage problems. Amaury now leads a group of consultants, focusing on the extension of N-SIDE’s solutions.

Next speaker
Back
Sean Smith
Biological Threat Exclusion Coordinator (BTEC), U.S. Customs and Border Protection

Sean Smith is a Biological Threat Exclusion Coordinator (BTEC) for CBP in the Office of Field Operations/ Agriculture Programs and Trade Liaison/ Biological Threat Exclusion. As a BTEC, Mr. Smith is charged with supporting and developing U.S. Customs and Border Protection (CBP) operational capacity and capability in preventing tools of agro/bio-terrorism from entering the U.S.  Mr. Smith has more than 17 years of public service with CBP, and has worked in a variety of environments, including on the southern land border, maritime, air passenger, and cargo locations.  He has also been able to assist in several past domestic and international CBP disaster recovery operations.

Session Details:

PANEL DISCUSSION: Mitigating unnecessary delays in clinical supply logistics: Huddle and Solutions

2023-12-05, 4:30 PM

Session Details:

Explore importing and exporting requirements for biological materials and how preparation is everything in the modern world

2023-12-06, 11:30 AM

View In Agenda
Next speaker
Back
Gina Reneau
Biological Threat Exclusion Coordinator, U.S. Customs & Border Protection

Gina Reneau is a Biological Threat Exclusion Coordinator (BTEC) for U.S. Customs and Border Protection (CBP) in the Office of Field Operations

Agriculture Programs and Trade Liaison/ Biological Threat Exclusion.  As a BTEC, Ms. Reneau is charged with supporting and developing CBP operational capacity and capability in preventing tools of agro/bio-terrorism from entering the U.S.  Ms. Reneau has more than 27 years of public service with CBP, and has worked in a variety of environments, including in air passenger, cargo, maritime, and express consignment locations.

Session Details:

Explore importing and exporting requirements for biological materials and how preparation is everything in the modern world

2023-12-06, 11:30 AM

View In Agenda
Next speaker
Back
Daniela Caiazza
Senior Director Clinical Services and Innovation, Novotech
Next speaker
Back
Marc van Pruijssen
General Manager Clinical Trial Services & Logistic Excellence and Global Head of Logistics, Sample Handling & CTOS, Viroclinics-DDL, a Cerba Research company
Next speaker
Back
YoungSu Noh
Director, Head of Clinical science, Hanmi Pharma
Next speaker

Plan Your Visit

Venue

JW Marriott Hotel Seoul

176, Sinbanpo-ro Seocho-gu, 6546, Seoul, South Korea

Sponsors

Select a sponsor to learn more

Featured Sponsor

Session Sponsor

Exhibitors

Co-Sponsors

Media Centre

Media Partners

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Ben Lloyd-Davis

Head of Healthcare Sponsorship

+44 207866 9497

SPEAKER ENQUIRIES

Ranhee Yoo

Conference Producer

+44 207947 2793

MARKETING ENQUIRIES

Haida Amirzadah

Marketing Manager

DELEGATE ENQUIRIES

Sunny Saikia

VIP Delegate Manager

Sponsorship Enquiries

Ben Lloyd-Davis

Head of Healthcare Sponsorship


+44 207866 9497

Speaker Enquiries

Ranhee Yoo

Conference Producer


+44 207947 2793